Anubha Sinha, MD
Gastroenterology · Flemington, NJNPI 1730107145
Payments from drug & device makers
Across 63 payments — averaging $20.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$461
- Sanofi-aventis U.S. LLC$179
- Johnson & Johnson$154
- Novo Nordisk$99
- Daiichi Sankyo Inc.$77
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$44
- plus $253 from 14 others
What the payments were for
- Food & beverage$1,00479%
- Education$26321%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 29 | $461 |
| Sanofi-aventis U.S. LLC | 2 | $179 |
| Johnson & Johnson | 6 | $154 |
| Novo Nordisk | 3 | $99 |
| Daiichi Sankyo Inc. | 5 | $77 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $44 |
| Braintree Laboratories, Inc. | 1 | $29 |
| Acera Surgical, Inc. | 1 | $27 |
| Sanofi | 1 | $21 |
| Abbott | 1 | $20 |
| GSK | 1 | $20 |
| Madrigal Pharmaceuticals | 1 | $19 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $16 |
| Bristol Myers Squibb | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
| Exact Sciences | 1 | $14 |
| QOL Medical, LLC | 1 | $14 |
| Pfizer | 1 | $13 |
| Alfasigma USA, Inc. | 1 | $12 |
How this compares
$1,267 in reported general payments places this provider in the 35th percentile of 701 gastroenterology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sucralfate | 16 | $1,678 |
| Omeprazole | 89 | $1,261 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 18 | $1,183 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 22 | $582 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 31 | $539 |
| Pantoprazole Sodium | 33 | $270 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Flemington
- Richard ArrigoFlemington$120K
- Kiran RaoSparta$1.3M
- Adekunle AdeotiIrvington$1.2M
- Carl WallachMorristown$766K
- Vinod RustgiNew Brunswick$697K
- Arvind TrindadeNew Brunswick$652K
- Barry KaufmanEgg Harbor Township$595K
- Promila BanerjeeStratford$522K
- Neil NagariaToms River$442K
- Zamir BrelviNewark$408K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.